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Abstract. 
 
Rho-associated kinase (Rho-kinase), which 
is activated by the small GTPase Rho, regulates forma-
tion of stress fibers and focal adhesions, myosin fiber 
organization, and neurite retraction through the phos-
phorylation of cytoskeletal proteins, including myosin 
light chain, the ERM family proteins (ezrin, radixin, 
and moesin) and adducin. Rho-kinase was found to 
phosphorylate a type III intermediate filament (IF) 
protein, glial fibrillary acidic protein (GFAP), exclu-
sively at the cleavage furrow during cytokinesis. In the 
present study, we examined the roles of Rho-kinase in 
cytokinesis, in particular organization of glial filaments 
during cytokinesis. Expression of the dominant-nega-
tive form of Rho-kinase inhibited the cytokinesis of 
 
Xe-
nopus
 
 embryo and mammalian cells, the result being 
production of multinuclei. We then constructed a series 
of mutant GFAPs, where Rho-kinase phosphorylation 
sites were variously mutated, and expressed them in 
type III IF-negative cells. The mutations induced im-
paired segregation of glial filament (GFAP filament) 
into postmitotic daughter cells. As a result, an unusu-
ally long bridge-like cytoplasmic structure formed be-
tween the unseparated daughter cells. Alteration of 
other sites, including the cdc2 kinase phosphorylation 
site, led to no remarkable defect in glial filament sepa-
ration. These results suggest that Rho-kinase is essen-
tial not only for actomyosin regulation but also for seg-
regation of glial filaments into daughter cells which in 
turn ensures correct cytokinetic processes.
Key words: intermediate filament ¥ glial fibrillary 
acidic protein (GFAP) ¥ Rho ¥ Rho-associated kinase ¥ 
cytokinesis
 
T
 
he
 
 Rho family of small GTPases appear to be key
players in various cellular processes; Rho, Rac, and
Cdc42, currently the best understood molecules,
control the adhesion, morphology, and motility of mam-
malian cells, and also regulate signal transduction path-
ways that affect gene transcription in the nucleus (for
review see Machesky and Hall, 1996; Hall, 1998). Rho
may also be involved in cytokinesis since inhibition of en-
dogenous Rho by 
 
botulinum
 
 ADP-ribosyltransferase C3
blocked cytokinesis in 
 
Xenopus
 
 embryo (Kishi et al., 1993)
and sand dollar (Mabuchi et al., 1993), perhaps due to in-
hibition of actin reorganization and contractile ring forma-
tion. In addition, in
 
 Xenopus 
 
embryos, Rho is apparently
important for assembly of actin filaments and proper con-
striction of the contractile ring, and Cdc42 has a role in
furrow ingression (Drechsel et al., 1996).
Rho cycles between GDP-bound inactive and GTP-
bound active forms, which binds to specific targets and
then exerts biological functions. Several Rho targets have
been identified: protein kinase N (PKN)
 
1
 
 (Amano et al.,
1996
 
a
 
; Watanabe et al., 1996), Rho-kinase/ROK
 
a
 
 (Leung
et al., 1995; Matsui et al., 1996), and the myosin-binding
subunit (MBS) of myosin phosphatase (Kimura et al.,
1996). p160
 
ROCK
 
 is an isoform of Rho-kinase (Ishizaki et al.,
1997). Rho-kinase regulates the phosphorylation of myo-
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1. 
 
Abbreviations used in this paper: 
 
aa, amino acid(s); CF, cleavage furrow;
EL cells, L cells that express E-cadherin; ERM, ezrin, radixin, and moesin;
IF, intermediate filament; GFAP, glial fibrillary acidic protein; MBS, my-
osin-binding subunit of myosin phosphatase; MLC, myosin light chain;
PH, pleckstrin homology; PI, propidium iodide; PKN, protein kinase N.
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sin light chain (MLC) of myosin II by direct phosphoryla-
tion of MLC and by inactivation of myosin phosphatase
through phosphorylation of MBS (Amano et al., 1996
 
b
 
;
Kimura et al., 1996; Chihara et al., 1997). In addition to
MLC and MBS, Rho-kinase phosphorylates the ERM
family proteins (ezrin, radixin, and moesin) and adducin
both in vitro and in vivo (Matsui et al., 1998; Fukata et al.,
1998; Kimura et al., 1998). Rho-kinase has been shown to
regulate the formation of actin stress fibers and focal adhe-
sions (Amano et al., 1997; Leung et al., 1996; Ishizaki et al.,
1997), smooth muscle contraction (Kureishi et al., 1997),
myosin fiber organization and
 
 c-fos
 
 expression (Chihara
et al., 1997), and neurite retraction (Amano et al., 1998).
Intermediate filaments (IFs) constitute major compo-
nents of the cytoskeleton and the nuclear envelope in most
cell types (for reviews see Eriksson et al., 1992; Fuchs and
Weber, 1994). Although IFs were considered to be rela-
tively stable compared with other cytoskeletons such as
actin filaments and microtubules, intensive in vitro investi-
gations revealed that site-specific phosphorylation of the
head domains of IF proteins by several kinases, such as
protein kinase A (PKA), protein kinase C (PKC), Ca
 
2
 
1
 
/
calmodulin-dependent protein kinase II (CaMKII) and
cdc2 kinase, dynamically alters the filament structure (for
review see Inagaki et al., 1996). However, it has remained
to be determined if the results obtained in vitro reflect the
physiological significance of IF phosphorylation in vivo.
During cytokinesis of cell division, the cleavage furrow
forms between the daughter nuclei, after which the es-
sential cell components are segregated into postmitotic
daughter cells. Protein phosphorylation/dephosphoryla-
tion is thought to play pivotal roles in mitotic processes
(Norbury and Hunt, 1991; Nurse, 1992; Nigg, 1993), and it
has been suggested that it may also regulate cellular sepa-
ration in cytokinesis (Satterwhite et al., 1992; Murray and
Hunt, 1993; Yamakita et al., 1994). We detected protein
kinase activity in the cytokinetic cells and this activity
phosphorylates a type III IF protein, glial fibrillary acidic
protein (GFAP) (Nishizawa et al., 1991; Matsuoka et al.,
1992; Sekimata et al., 1996; Kosako et al., 1997) at meta-
phaseÐanaphase transition at the cleavage furrow. We
named the putative kinase cleavage furrow (CF) kinase.
We then found that in vivo phosphorylation sites of GFAP
(Thr-7, Ser-13, and Ser-38) by CF kinase is located in the
head domain and completely overlapped with in vitro
GFAP phosphorylation sites by Rho-kinase, and that the
phosphorylation of GFAP head domain by Rho-kinase led
to disassembly of the filament structure in vitro (Kosako
et al., 1997). Moreover, Rho-kinase and its regulator Rho
were immunocytochemically shown to be concentrated at
the cleavage furrow (Takaishi et al., 1995; Kosako et al.,
1998). Taken together, we consider that Rho-kinase func-
tions as a CF kinase for GFAP.
In the present study, we examined roles of Rho-kinase
in cytokinesis, and found that the dominant-negative form
of Rho-kinase inhibited cleavage furrow formation in 
 
Xe-
nopus
 
 embryos and cytokinesis of mammalian EL cells.
We also analyzed functions of the specific phosphorylation
of GFAP by Rho-kinase during cytokinesis. For this pur-
pose, we constructed a series of mutant human GFAPs,
where Rho-kinase phosphorylation sites Thr-7, Ser-13,
and/or Ser-38 are substituted to Ala, and expressed them
in type III IF-negative cells, T24. Mutations in the Rho-
kinase phosphorylation sites specifically impaired segre-
gation of glial filament into postmitotic daughter cells.
Consequently, an unusually long bridge-like cytoplasmic
structure formed between unseparated daughter cells, and
Ser-38 was found to be prerequisite for this phenotype. On
the basis of these observations, we propose that Rho-
kinase is involved in not only the actomyosin system but
also in IF reorganization during cytokinesis.
 
Materials and Methods
 
Gene Construction 
 
For expression of wild-type GFAP, cDNA for human GFAP (Reeves et al.,
1989) was introduced in the expression vector pDR2 (Clontech, Palo Alto,
CA). For site-directed mutagenesis, we used polymerase chain reaction
(PCR) with oligonucleotide mutation primers and the template GFAP
cDNA. The cDNA fragment of RB/PH (TT), encoding Rho-binding do-
main with point mutations (Asn1036 and Lys1037 to Thr) and pleckstrin
homology (PH) domain, was subcloned into the pMAL-c2 vector and ex-
pressed in 
 
Escherichia coli 
 
as maltose-binding protein (MBP) fusion pro-
tein and purified on amylose resin (New England Biolabs, Beverly, MA).
RB/PH (TT) was reported to function as a dominant-negative version of
Rho-kinase (Amano et al., 1998). The mutation sites were confirmed by
sequencing using the dideoxy termination method and a DNA sequencer
(Applied Biosystems, Foster City, CA).
 
Microinjection into Xenopus Eggs 
 
Proteins used were concentrated and replaced by microinjection buffer
(88 mM NaCl, 20 mM Tris-Cl, pH 7.5) with Centricon 10 (Amicon, Bev-
erly, MA). Eggs from 
 
Xenopus laevis
 
 were fertilized in vitro and cultured
in 0.1
 
3 
 
MBS (8.8 mM NaCl, 0.1 mM KCl, 0.041 mM CaCl
 
2
 
, 0.033 mM
Ca(NO
 
3
 
)
 
2
 
, 0.082 mM MgSO
 
4
 
, 0.24 mM NaHCO
 
3
 
, 1 mM Hepes, pH 7.4)
containing 3% Ficoll. The embryos were selected at the beginning of the
first furrow and 10 nl of protein sample was injected 
 
z
 
100 min after fertil-
ization into one blastomere. Cleavage arrest of the injected blastomere
was observed 2.5 h after fertilization.
 
Transfection 
 
Mouse fibroblastic L cells which express E-cadherin (EL cells) were main-
tained in DME supplemented with 10% FCS. Transfection of plasmids
into EL cells was carried out using lipofectamine (GIBCO BRL, Gaithers-
burg, MD). Human bladder cell carcinoma T24 cells maintained in DME
supplemented with 10% FCS in a 37
 
8
 
C, 5% CO
 
2
 
 incubator were cotrans-
fected with pCMVEBNA (Clontech) and pSV2neo (Clontech) plasmids
using lipofectamine. Cells expressing pCMVEBNA were cloned and
maintained in the presence of 500 
 
m
 
g/ml G418 sulfate (GIBCO BRL).
The EBNA-expressing T24 cells were transiently transfected with wild-
type or mutant GFAP cDNA in pDR2, using lipofectamine, then were ex-
amined immunocytochemically or by immunoblotting 48 h after the trans-
fection. In some experiments, mitotic cells were prepared as follows. 48 h
after transfection, cells were treated with 15 ng/ml 3-(1-anillinoeth-
ylidene)-5-benzylpyrrolidine-2,4-dione (TN-16) (Wako Chemical, Neuss,
Germany) for 4 h and mitotic cells were collected. After washing with
DME to remove TN-16, cells were plated on glass coverslips, and then in-
cubated for 3 h at 37
 
8
 
C in DME containing 10% FCS to allow cell cycle
progression. Then, the GFAP bridge formation was analyzed by immuno-
cytochemistry.
 
Immunocytochemistry and Immunoblotting 
 
EL cells were seeded at a density of 1.7 
 
3 
 
10
 
4
 
 cells onto 13-mm glass cov-
erslips coated with polylysine (Sigma Chemical Co., St. Louis, MO). pEF-
Bos-myc vectors encoding the coil region of Rho-kinase (amino acids [aa]
421Ð701) or RB/PH (TT) were transfected using lipofectamine reagent
(GIBCO BRL). The nuclei and expressed proteins were stained with bis-
benzimide (Molecular Probes, Eugene, OR) and polyclonal anti-myc anti-
body (Santa Cruz Biotechnology, Santa Cruz, CA), respectively (Amano
et al., 1998). For the control experiment, pEF-Bos-myc vector was mixed 
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in a 4:1 ratio with pME18S-lacZ. To visualize cells expressing 
 
b
 
-galactosi-
dase, the cells were placed in fixation solution (2% formaldehyde, 0.2%
glutaraldehyde in PBS) for 10 min at room temperature and washed three
times with PBS. Cells were stained with antiÐ
 
b
 
-galactosidase antibody
(Chemicon, Temecula, CA).
Immunocytochemical procedures using the antibodies MO389, YC10,
KT13, KT34, pG1-T and the following propidium iodide (PI) staining
have been described elsewhere in detail (Matsuoka et al., 1992; Sekimata
et al., 1996). For double immunostaining with anti-lamin A/C and anti-
GFAP antibodies, cells were fixed with 
 
2
 
20
 
8
 
C methanol for 10 min and
then were incubated with monoclonal anti-lamin A/C antibody (provided
by Y. Yoneda, Osaka University, Osaka, Japan) diluted 1:1,000 in PBS
and polyclonal anti-GFAP antibody (Dako, Carpinteria, CA) diluted
1:200 in PBS for 2 h. The lamin A/C immunoreactivity was visualized by
incubation with biotinylated anti-mouse IgM antibody (Vector Laborato-
ries, Burlingame, CA), followed by incubation with streptavidin-Texas red
(Amersham, Arlington Heights, IL), whereas the GFAP immunoreactiv-
ity was visualized by FITC-conjugated anti-rabbit antibodies (BioSource,
Camarillo, CA). For double immunostaining with anti-tubulin and anti-
GFAP antibodies, cells fixed as above were incubated with monoclonal
antiÐ
 
a
 
-tubulin antibody (Sigma Chemical Co.) diluted 1:500 in PBS and
the polyclonal anti-GFAP antibody for 2 h, and the former immunoreac-
tivity was visualized by use of Texas redÐconjugated anti-mouse IgG anti-
body (Amersham). For double staining of actin and GFAP, cells fixed
with 3.7% formaldehyde in PBS for 15 min, followed by treatment with
0.1% Triton X-100 in PBS, and then stained by incubation with
rhodamine phalloidin (Molecular Probes) diluted 1:1,000 in PBS and the
polyclonal anti-GFAP antibody for 2 h.
For immunoblotting, lysates of 2 
 
3 
 
10
 
4 
 
cells were loaded in the lanes,
resolved by SDS-PAGE, and then transferred onto a polyvinylide difluo-
ride membrane (Immobilon-P; Millipore, Waters Chromatography, Mil-
ford, MA). The blots were then incubated overnight with polyclonal anti-
GFAP antibody (Dako) diluted 1:500 in TBS-T (20 mM Tris, pH 7.6, 137
mM NaCl, 0.1% Tween 20). Immunoreactive bands were visualized by use
of horseradish peroxidase-conjugated anti-rabbit antibody (Amersham)
and the enhanced chemiluminescence Western blotting detection system
(Amersham).
 
Results
 
Dominant-negative Rho-Kinase Blocks Cytokinesis in 
Xenopus Embryos and Mammalian EL Cells
 
To analyze the function of Rho-kinase on cytokinesis, we
used a polypeptide, RB/PH (TT), which contains a mu-
tated Rho-binding domain and PH-domain of Rho-kinase
(aa 941Ð1,388) and acts as a dominant-negative form of
Rho-kinase (Amano et al., 1998). We have recently found
that RB/PH (TT) specifically inhibits the kinase activity of
Rho-kinase, but not the activity of PKN or myotonic
dystrophy kinase-related Cdc42-binding kinase (MRCK)
(Leung et al., 1998), which has a kinase domain similar to
that of Rho-kinase (our unpublished observation). When
 
Xenopus 
 
embryos, which are known to have a counterpart
of Rho-kinase (Farah et al., 1998), were fertilized by 
 
Xe-
nopus
 
 sperm, the furrow formation started 
 
z
 
90 min after
fertilization and the cytoplasmic division was completed
within 
 
z
 
5 min. When MBP-fused RB/PH (TT) (10 mg/ml)
or recombinant C3 (2.5 
 
m
 
g/ml) was microinjected into one
blastomere of 
 
Xenopus
 
 embryo at 100 min after the fertili-
zation (two-cell stage), the cleavage furrow formation was
blocked, and a white belt appeared on the equatorial re-
gion in the animal hemisphere of the embryos, instead of
the furrow (Fig. 1 and Table I). Under these conditions, a
well-developed cleavage furrow was observed in the con-
trol embryos microinjected with buffer or MBP (Fig. 1).
Interference with cleavage furrow formation was also ob-
served when the PH-domain of Rho-kinase (aa 1,125Ð
1,388), which is known to be a weak dominant-negative
form (Amano et al. 1998), was microinjected; the furrow
formation was somewhat delayed compared with findings
with the buffer control (data not shown). When we ana-
lyzed the effect of dominant-negative Rho-kinase using
mammalian cells, expression of the RB/PH (TT) in EL
cells also interfered with cleavage furrow formation (Fig.
2). By contrast, chromosome separation and movement
towards the poles of mitotic apparatus, as well as daughter
nuclei formation, occurred normally. Consequently, the
transfected cells became multinuclear (Fig. 2). Approxi-
mately 20% of the cells expressing RB-PH (TT) had
multinuclei 120 h after transfection (Fig. 2 
 
B
 
). We con-
clude that Rho-kinase plays essential roles in cleavage fur-
row formation.
Figure 1. Effects of C3 or the dominant-negative form of Rho-
kinase on furrow formation in Xenopus embryos. Microinjection
buffer, C3 (2.5 mg/ml), MBP (10 mg/ml), or MBP-RB/PH (TT)
(10 mg/ml) was injected into one blastomere at the two-cell stage.
Photographs of the embryos were taken 2.5 h after fertilization.
The results shown are representatives with typical phenotype.
 
Table I. Effects of C3 or the Dominant-negative Form of
Rho-kinase on Furrow Formation
 
Number of embryos
Failed
cleavage Total
Failed cleavage
with white belt
 
%
 
Buffer Ñ 11 0 0
C3 2.5 
 
m
 
g/ml 29 27 93
MBP 10 mg/ml 22 0 0
MBP-RB/PH (TT) 10 mg/ml 45 28 62 
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Expression of GFAP in T24 Cells Lacking Type III IFs
 
CF kinase/Rho-kinase activity was reported to phosphory-
late Thr-7, Ser-13, and Ser-38 of human GFAP, an astro-
cyte specific IF protein, at the cleavage furrow of cytoki-
netic cells (Nishizawa et al., 1991; Matsuoka et al., 1992;
Sekimata et al., 1996; Kosako et al., 1997) (Fig. 3 
 
A
 
). It has
been considered that Rho-kinase acts as a CF kinase to-
ward GFAP and vimentin (Kosako et al., 1997; Goto et al.,
1998; Kosako et al., 1998). We asked whether ectopically
expressed GFAP can be phosphorylated even in cells lack-
ing type III IFs. As shown in Fig. 3 
 
B
 
, wild-type GFAP
transiently expressed in T24 cells, which do not express
any type III IFs, was diffusely distributed in the cytoplasm.
We stained the cells with monoclonal antibodies that rec-
ognize site-specific phosphorylation of GFAP (Matsuoka
et al., 1992; Sekimata et al., 1996) and rabbit polyclonal an-
tibody for GFAP (Dako). The obtained results confirmed
that the ectopically expressed wild-type GFAP was also
phosphorylated at Thr-7, Ser-13, and Ser-38 at the cleav-
age furrow of cytokinetic T24 cells (Fig. 3 
 
B
 
). Another mi-
totic kinase, cdc2 kinase, also phosphorylated GFAP at
Ser-8 in metaphase cells (Fig. 3 
 
B
 
), as noted earlier (Mat-
suoka et al., 1992; Inagaki et al., 1996). The obtained data
coincide with the finding that Rho-kinase and cdc2 kinase
are expressed ubiquitously. T24 cells expressing wild-type
GFAP underwent normal mitosis and cell growth (Fig. 3 
 
B
 
and
 
 
 
Fig. 4 
 
B
 
).
 
Effects on Cytokinesis of Mutation of GFAP in
Rho-Kinase Phosphorylation Sites
 
To determine the significance of GFAP phosphorylation
by Rho-kinase, we constructed a mutant GFAP, m(7,13,38),
with mutations in Rho-kinase phosphorylation sites (Fig. 3
 
A
 
) and transiently expressed this mutant in T24 cells, using
the pDR2 vector system. Fig. 4 
 
A
 
 indicates that expression
patterns of wild-type GFAP and m(7,13,38) mutant in
interphase cells are indistinguishable; in some cells, ex-
pressed wild-type GFAP or the m(7,13,38) mutant ap-
peared to be enriched at the perinuclear area and, in other
cells, expressed GFAP formed an extended network
from the perinuclear region to the cell periphery. Cells ex-
pressing the mutant had a normal morphology at pro-
metaphase, metaphase, anaphase, and telophase (data not
shown). At T24 cells expressing m(7,13,38), the percent-
age of mitotic cell population in the total transfected cells
was 3.4%, a value comparable to that in the case of cells
expressing wild-type and other mutated GFAP (Fig. 5 
 
A
 
).
However, cells expressing m(7,13,38) showed a striking
phenotype after passing through telophase. The mutant
GFAP filaments failed to segregate into daughter cells and
Figure 2. Effects of dominant-negative form of Rho-kinase on
cytokinesis in EL cells. (A) EL cells were transiently transfected
with either pEF-BOS-myc vector (panel a), pEF-BOS-myc-
COIL  (panel  b), or pEF-BOS-myc-RB/PH (TT) (panel c ).
pME18S-lacZ was cotransfected with control vector to identify
the transfected cells. 72 h after the transfection, the cells were
fixed and stained for b-galactosidase (panel a) and myc-tagged
protein (panels b and c). (B) 72 h (open column) or 120 h
(hatched column) after the transfection of plasmids encoding in-
dicated cDNAs, the cells were fixed and stained for b-galactosi-
dase activity. The percentage of LacZ-positive cells bearing
multinuclei was scored. Data are means 6 SEM of at least tripli-
cate determinations. At least 200 cells per each sample were
counted and at least three independent experiments were per-
formed. Bar, 40 mm. 
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formed an unseparated bridge-like structure between
them (Fig. 4
 
 B
 
, Fig. 5 
 
A
 
, and Fig. 6). As a result, the daugh-
ter cells were left unseparated. Cells forming such an un-
usual bridge accounted for 7.3% of the total m(7,13,38)-
expressing cells 48 h after the transfection (Fig. 5 
 
A
 
). As
shown in Fig. 5 
 
B
 
, Western blot analysis confirmed that
the GFAP mutant was expressed comparably to the wild
type. To further confirm the effects of m(7,13,38) parallel to
wild type on cytokinesis, we synchronized the cells to mi-
totic phase with TN-16 as described in Materials and
Methods and analyzed the GFAP bridge formation. As
shown in Table II, the percentage of the cells with
GFAP bridge dramatically increased (
 
6
 
8%) by m(7,13,38),
whereas the wild-type showed no bridge formation (0%),
supporting the hypothesis that phosphorylation of GFAP
by Rho-kinase is essential for proper cytokinesis. Fig. 6
shows examples of unseparated cells expressing m(7,13,38).
Cells often formed very long GFAP bridges, some of
which reached more than five times the cell diameter (Fig.
6 
 
g
 
). In addition, bridges were often torn off between
daughter cells (Fig. 6, 
 
e 
 
and 
 
f
 
, 
 
arrowheads
 
).
 
Intracellular Bridge Formation Is a
Specific Phenomenon in m(7,13,38)-expressing Cells
 
To rule out the possibility that the phenotype can be
induced by nonsite-specific mutation of three possible
GFAP phosphorylation sites, we prepared the mutants
Figure 3. (A) Schemes showing GFAP
phosphorylation sites and GFAP mutants
produced in this study. Phosphorylation
sites for PKA, PKC, CaMKII, cdc2 kinase,
and Rho-kinase were identified in in vitro
studies, whereas those for CF kinase were
identified in in vivo sites. The sites are in-
dicated by P within a circle. Note that Ser-
38 of human GFAP (Reeves et al., 1989)
corresponds to Ser-34 of bovine GFAP
(Inagaki et al., 1996). (B) Cell cycle-
dependent site-specific phosphorylation
of wild-type GFAP expressed in T24 cells.
The cells were immunostained by anti-
GFAP antibody MO389 (top), YC10 that
recognizes GFAP phosphorylation at Ser-8
(middle), or by KT13 that recognizes
GFAP phosphorylation at Ser-13 (bot-
tom). Ser-8 of GFAP was phosphorylated
by cdc2 kinase at metaphase, whereas Ser-
13 was phosphorylated by CF kinase in the
cleavage furrow of cytokinetic cells. The
antibodies pG1-T and KT34 that recog-
nize GFAP phosphorylation at Thr-7 and
Ser-38, respectively, showed that these
sites are also phosphorylated by CF kinase
at the cleavage furrow (data not shown).
The green fluorescence represents the
immunoreactions. The chromosomes were
stained by PI (red fluorescence). Bar, 10 mm. 
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m(8,16,35), m(8,17,35), m(8,16,17), and m(16,17,35) in
which three Ser/Thr different from the Rho-kinase sites
were altered (Fig. 3 
 
A
 
). None of these mutants showed any
remarkable phenotype (Fig. 5
 
 A
 
). Previous studies demon-
strated that mutations in cdc2 kinase phosphorylation sites
of other IF proteins, lamin and vimentin, led to inhibition
of nuclear lamina and vimentin filament disassembly, re-
spectively, in early mitotic phases but not in cytokinesis
(Heald and McKeon, 1990; Chou et al., 1996). We pro-
duced a mutant m(8) in which the cdc2 kinase phosphory-
lation site Ser-8 of GFAP (Inagaki et al., 1996) was altered
(Fig. 3 
 
A
 
). In contrast to m(7,13,38), T24 cells expressing
m(8) underwent cytokinesis normally and did not show
GFAP bridge formation (Fig. 5 
 
A
 
).
As a next set of experiments, we tried to establish the
stable cell lines expressing m(7,13,38) by use of various ex-
pression plasmids such as pDR2, pCMVneo, and pEF-Bos.
We realized that it was difficult to establish m(7,13,38)-
expressing cells under the conditions in which many hy-
gromycin- or G418-resistant cell lines were obtained, since
Figure 4. Mutations in the CF kinase/Rho-associated kinase phosphorylation sites impair GFAP segregation into postmitotic daughter
cells. (A) Localization of wild-type GFAP and m(7,13,38) in interphase T24 cells. (B) Postmitotic T24 cells expressing wild-type GFAP
and the mutant m(7,13,38). The green fluorescence represents GFAP immunoreactivity stained with MO389, whereas the chromosomes
were stained by PI (red fluorescence). Bars: (A) 10 mm; (B) 40 mm.
Figure 5. Effects by various
mutants on the formation of
GFAP bridge-like structure.
(A) Population of mitotic
cells (open column) and cells
forming the bridge-like struc-
ture (closed column) ex-
pressing GFAP of wild-type,
m(8), m(7,13,38), m(8,16,35),
m(8,17,35), m(8,16,17), or
m(16,17,35). The two daugh-
ter cells linked by one bridge-
like structure was counted as
one cell. (B) Western blot
analysis of wild-type and mu-
tant GFAPs expressed in T24
cells.Yasui et al. Phosphorylation Essential for Cytokinetic Segregation of Glial Filaments1255
the expression level of GFAP is so low that the protein did
not form filamentous structure throughout cytoplasm
(data not shown).
To minimize the artifact due to the lipofectamine tran-
sient transfection, we coexpressed m(7,13,38) with wild-
type GFAP, and found that wild-type GFAP reversed the
phenotype of m(7,13,38)-transfected cells (data not shown).
This observation indicates that wild-type GFAP titrated
out the mutant GFAP in cells and consequently the inter-
cellular GFAP bridge formation was not observed. Thus,
we conclude that the bridge formation caused by the
m(7,13,38) is not an artifact due to the lipofectamine tran-
sient transfection.
Taken together, the obtained results indicate that the
GFAP bridge was induced by site-specific mutations at
Rho-kinase phosphorylation sites. Thus, this kinase plays
an essential role in proper cytokinetic segregation of glial
filaments.
Effects of Single and Double Mutations at
Rho-Kinase Phosphorylation Sites on Formation of
the GFAP Bridge-like Structure
In the next set of experiments, we wanted to determine the
phosphorylation site which induces the m(7,13,38) pheno-
type. We introduced single or double mutations at Thr-7,
Ser-13, and Ser-38. As depicted in Table III, Ser-38 was
found to be the most important phosphorylation site for
the proper segregation of glial filaments, since the muta-
tion in this position resulted in the most prominent rela-
Figure 6. GFAP bridge-like structures in T24 cells expressing m(7,13,38). The green color represents GFAP immunoreactivity stained
with MO389, whereas the red color shows chromosomes stained by PI. Bar, 10 mm.The Journal of Cell Biology, Volume 143, 1998 1256
tive score of bridge-like structure. A single mutation at
Thr-7 or Ser-13 was much less effective compared with
Ser-38. Interestingly, an additional single mutation to Ser-
38 had a synergistic effect on formation of the bridge-like
structure.
Effects of Mutation in Rho-Kinase
Phosphorylation Sites on the Reorganization of Other 
Cytoskeletal Components
To examine effects of the m(7,13,38) mutant on functions
of other cytoskeletal components during cytokinesis, we
analyzed the unseparated cells expressing the mutant
m(7,13,38) (Fig. 7). Immunostaining with anti-lamin A/C
antibody revealed the existence of a reformed nuclear
lamina in each daughter cell (Fig. 7, a and b). The contrac-
tile ring of actin filaments and the midbody of microtu-
bules had disappeared in the bridge between the daughter
cells (Fig. 7, cÐf), which means that bridge-forming cells
had completed cytokinetic processes but that segregation
of the GFAP filaments was not finished. Under this condi-
tion, keratin 7 and 18, the endogenous IFs of T24 cells, was
segregated properly (data not shown).
Discussion
Rho-kinase is a downstream target for Rho (Leung et al.,
1995; Matsui et al., 1996; Ishizaki et al., 1997). Rho has
been considered to participate in cytokinesis (Mabuchi et al.,
1993; Kishi et al., 1993; Drechsel et al., 1996). Molecular
mechanisms of Rho functions in this cellular process are
not clear. Here, by using dominant-negative Rho-kinase,
RB/PH (TT), we first provide direct evidence that this ki-
nase plays an essential role during cytokinesis, since it
blocks cleavage furrow formation in the Xenopus embryo
system. Inhibition of cytokinesis was also observed in RB/
Table II. Effect of Synchronization of the Cells on Formation of 
GFAP Bridge-like Structures
Number of cells
Percent Total Formation of GFAP bridge
Wild type 200 0 6 00   6 0
m(7,13,38) 200 135 6 15 68 6 8
The results are expressed as the mean 6 SD of three independent experiments. At
least 200 cells per each sample were counted.
Table III. Effect of Single and Double Mutations at Thr 7, Ser 
13, and Ser 38 on Formation of GFAP Bridge-like Structures
Mutants Relative scores of bridge-like structure
%
m(7,13,38) 100
Wild type 0 6 0
m(7) 1.3 6 0.49
m(13) 4.8 6 3.4
m(38) 26 6 1.6
m(7,13) 8.7 6 1.8
m(7,38) 43 6 12
m(13,38) 81 6 2.5
Population of cells with GFAP bridge-like structures relative to that of m(7, 13, 38)
was scored. The results are expressed as the mean 6 SD of three independent experi-
ments. In each experiment, at least 2,000 cells were counted.
Figure 7. Analysis of the nu-
clear membrane, actin fila-
ments, and microtubles in
T24 cells forming GFAP
bridge-like structures. T24
cells expressing m(7,13,38)
were double-stained by anti-
lamin A/C antibody (a) and
polyclonal anti-GFAP anti-
body (Dako) (b), rhodamine
phalloidin (c), and polyclonal
anti-GFAP antibody (Dako)
(d), or anti-tubulin antibody
(e) and polyclonal anti-
GFAP antibody (Dako) (f).
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PH (TT)-expressing mammalian EL cells, where the cells
became multinuclear. Together with the finding that RB/
PH (TT) inhibits only Rho-kinase activity but not PKN
(Mukai and Ono, 1994) or MRCK (Leung et al., 1998) ac-
tivity, these results strongly suggest that Rho-kinase regu-
lates cytokinesis. One possible explanation for the results
obtained with Xenopus embryos and EL cells is that Rho-
kinase phosphorylates substrate(s) such as MBS (Kimura
et al., 1996) and myosin light chain (Amano et al., 1996b),
which are involved in contractile ring formation and its
maintenance, and therefore RB/PH (TT) would be ex-
pected to interfere with the cytokinesis process at the step
of cleavage furrow formation.
To elucidate the Rho-kinase function in spatiotemporal
organization of glial filaments during cytokinetic process,
we asked if phosphorylation of GFAP at Thr-7, Ser-13,
and Ser-38 by Rho-kinase is responsible for the in vivo dis-
assembly of glial filaments. Since the introduction of dom-
inant-negative Rho-kinase into Xenopus embryos or EL
cells did not provide the direct link between Rho-kinase
and GFAP function, we made use of mutational analyses.
Mutations in the Rho-kinase phosphorylation sites of
GFAP (Thr-7, Ser-13, and Ser-38) resulted in impaired
segregation of glial filaments in cytokinetic cells, thereby
indicating that Rho-kinase has an essential role in proper
segregation of glial filaments. To further characterize the
significance of Rho-kinaseÐdependent phosphorylation of
GFAP in cytokinetic segregation of glial filaments, we in-
troduced a single or double mutation and found that Ser-
38 is essential for the long bridge-like cytoplasmic struc-
ture. When compared with nonsite-specific mutants such
as m(8,16,35), a single point mutation at Thr-7 or Ser-13
had a weak but consistent effect on GFAP bridge-like
structure. It must be noted that an additional single point
mutation at Thr-7 or Ser-13 to Ser-38 mutation has syner-
gistic effects, although the full effect was observed only
when Thr-7, Ser-13, and Ser-38 were all mutated. These
data suggest that triphosphorylation at these sites is re-
quired for efficient segregation of glial filaments. These re-
sults with the mutants indicate that phosphorylation of
GFAP at Thr-7, Ser-13, and Ser-38 facilitates disassembly
of glial filaments at cleavage furrow as expected by the in
vitro experiments (Kosako et al., 1997). However, it is no-
table that actual in vivo phosphorylation level at these
three sites is not determined, and it may be possible that
GFAP molecules are variously phosphorylated at cleavage
furrow of living cells. This interpretation is consistent with
the observation that GFAP phosphorylated by Rho-kinase
appears to be localized at the furrow region (Fig. 3 B, bot-
tom right panel) and is not totally solubilized as observed
in in vitro study (Kosako et al., 1997). Taken together, the
results presented here clarified that Rho-kinase is in-
volved in cytokinesis by not only regulating the actomyo-
sin cytoskeleton but also by regulating the IF cytoskeleton.
In the present study, we used T24 cells, which do not
contain Type III IF, to analyze the biological effects of
GFAP mutants on cytokinesis. One would argue that, in
T24 cells, type III IF has no physiological role in cytokine-
sis since T24 cells can complete cytokinesis without type
III IFs. The reason why we use T24 cells in the present
study is to show the physiological importance of GFAP
phosphorylation at Thr-7, Ser-13, and Ser-38 under the
conditions where any artifact by endogenous type III IF(s)
is excluded. Consequently, we could show that m(7,13,38)
mutant impairs completion of cytokinesis even if endoge-
nous IF in T24 cells segregates properly.
Rho-kinase is expressed not only in glial cells but also in
other types of cells (Leung et al., 1996; Matsui et al., 1996;
Ishizaki et al., 1997). It also phosphorylates another IF
protein vimentin at the cleavage furrow of cytokinetic cells
(Goto et al., 1998). Therefore, Rho-kinase may be suffi-
cient for the separation of other IFs during cytokinesis.
In summary, we observed functional effects of Rho-
kinaseÐdependent phosphorylation of GFAP with a vari-
ety of approaches; microinjection of dominant-negative
Rho-kinase (RB/PH [TT]) into Xenopus embryos, expres-
sion of it in EL cells, and expression of various GFAPs
with mutations at Rho-kinase phosphorylation sites in T24
cells. Like C3 enzyme, RB/PH (TT) blocked cleavage fur-
row formation, suggesting that Rho-kinase is involved in
contractile ring formation, under the control of Rho. It is
likely that Rho-kinase plays at least two roles in the reg-
ulation of cytokinesis. One role is to control the contrac-
tility of actin-myosinÐbased contractile ring, to proceed
cleavage furrow formation of the cell. The other is to phos-
phorylate IF proteins and depolymerize IFs at the cleav-
age furrow to accomplish cytokinesis (Fig. 8). Rho is
thought to regulate Rho-kinase and other targets simulta-
neously, so phenotype by RB/PH (TT) might be milder
than that of C3. The Rho-kinase phosphorylation site-spe-
cific mutation demonstrated a phenotype, which fails to
segregate GFAP filaments and consequently possesses un-
usually long bridge-like cytoplasmic structures. Analysis
with single and double mutations at Rho-kinase phosphor-
ylation sites revealed that phosphorylation at Ser-38 is the
most important for segregation of glial filaments. Based on
these findings we conclude that GFAP phosphorylation
has definitive roles in governing regulatory processes in
assembly-disassembly of glial filaments and turnover of
GFAP not only in vitro but also in vivo. This is the first in
vivo data that Rho-kinase regulates cytokinesis through
Figure 8. Signaling pathways from Rho for cytokinesis.The Journal of Cell Biology, Volume 143, 1998 1258
cleavage furrow formation and segregation of glial fila-
ments.
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